Gene · 1399
Papers2,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive DNA methylation profiling by MeDIP-NGS identifies potential genes and pathways for epithelial ovarian cancer. | J Ovarian Res | 2024 | 38627856 | PubTator, text mining | PubMed |
| Variants in Candidate Genes for Phenotype Heterogeneity in Patients with the 22q11.2 Deletion Syndrome. | Genet Res (Camb) | 2024 | 38586596 | PubTator, text mining | PubMed |
| Novel molecular subtypes of intracranial germ cell tumors expand therapeutic opportunities. | Neuro Oncol | 2024 | 38430549 | PubTator, text mining | PubMed |
| CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma. | J Hepatol | 2024 | 38403027 | PubTator, text mining | PubMed |
| Regulation and tumor-suppressive function of the miR-379/miR-656 (C14MC) cluster in cervical cancer. | Mol Oncol | 2024 | 38400534 | PubTator, text mining | PubMed |
| Digital spatial profiling of segmental outflow regions in trabecular meshwork reveals a role for ADAM15. | PLoS One | 2024 | 38394161 | PubTator, text mining | PubMed |
| Exploring the short linear motif-mediated protein-protein interactions of CrkL through ProP-PD. | Biochem Biophys Res Commun | 2024 | 38387229 | PubTator, text mining | PubMed |
| 3D genomic analysis reveals novel enhancer-hijacking caused by complex structural alterations that drive oncogene overexpression. | bioRxiv | 2024 | 38328209 | PubTator, text mining | PubMed |
| Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression. | J Exp Clin Cancer Res | 2024 | 38291438 | PubTator, text mining | PubMed |
| Vitamin D-mediated tsRNA-07804 triggers mitochondrial dysfunction and suppresses non-small cell lung cancer progression by targeting CRKL. | J Cancer Res Clin Oncol | 2024 | 38289488 | PubTator, text mining | PubMed |
| CRISPRing KRAS: A Winding Road with a Bright Future in Basic and Translational Cancer Research. | Cancers (Basel) | 2024 | 38275900 | PubTator, text mining | PubMed |
| Post-Irradiation Breast Angiosarcoma: All the Possible Treatments and Electrochemotherapy. Case Report and Literature Review. | J Clin Med | 2024 | 38256700 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Reelin in the Enteric Nervous System and the Microbiota-Gut-Brain Axis: Implications for Depression and Antidepressant Therapy. | Int J Mol Sci | 2024 | 38255890 | PubTator, text mining | PubMed |
| Potential role of RhoA GTPase regulation in type interferon signaling in systemic lupus erythematosus. | Arthritis Res Ther | 2024 | 38243295 | PubTator, text mining | PubMed |
| Lung adenocarcinoma with brain metastasis detected dual fusion of LOC399815-ALK and ALK-EML4 in combined treatment of Alectinib and CyberKnife: A case report. | Medicine (Baltimore) | 2024 | 38241569 | PubTator, text mining | PubMed |
| Secretome Analyses Identify FKBP4 as a GBA1-Associated Protein in CSF and iPS Cells from Parkinson's Disease Patients with GBA1 Mutations. | Int J Mol Sci | 2024 | 38203854 | PubTator, text mining | PubMed |
| SH2 domain protein E and ABL signaling regulate blood vessel size. | PLoS Genet | 2024 | 38190417 | PubTator, text mining | PubMed |
| Contribution of genetic variants to congenital heart defects in both singleton and twin fetuses: a Chinese cohort study. | Mol Cytogenet | 2024 | 38178226 | PubTator, text mining | PubMed |
| Dynamic network curvature analysis of gene expression reveals novel potential therapeutic targets in sarcoma. | Sci Rep | 2024 | 38177639 | PubTator, text mining | PubMed |
Modulation of mitochondrial activity by sugarcane (Saccharum officinarum L.) top extract and its bioactive polyphenols: a comprehensive transcriptomics analysis in C2C12 myotubes and HepG2 hepatocytes. | Nat Prod Bioprospect | 2024 | 38177614 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1399/papers?page=4